Assessing hepatitis B virus serologies when transitioning patients from intravenous immune globulin therapy to rituximab for the treatment of autoimmune neuromuscular diseases
Year: 2024
Type: article
Study design: Observational Study
Source: Muscle & Nerve
DOI: 10.1002/mus.28253
Authors: Nicole M. Hahn, Lara W. Katzin
Institution: Kaiser Permanente
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402530952